CAS Medical today announced that it has closed a private placement with Thomas, McNerney & Partners for the issuance of a combination of a Convertible Preferred Stock and non-voting Exchangeable Preferred Stock for gross proceeds of $15M. The Company intends to use the proceeds to fund its ongoing operating and growth initiatives related to its FORE-SIGHT Absolute Tissue Oximeter business and its Traditional Monitoring Products segment. :theflyonthewall.com
News For CASM From The Last 14 Days
Check below for free stories on CASM the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
